|
Guillamon CF, Martinez-Sanchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martinez-Garcia J, Martinez-Escribano J, Torroba A, Ferri B, Abellan DJ, Legaz I, Lopez-Alvarez MR, Moya-Quiles MR, Muro M, Minguela A. Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance. Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25. PubMed PMID: 31239317.
AÑO: 2019; IF: 8.728
|
31239317
|
Cascales Campos P, Martinez Insfran LA, Wallace D, Gil J, Gil E, Gonzalez Gil A, Martinez J, Alonso Romero JL, Gonzalez Sanchez R, Parrilla P. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. Clin Transl Oncol. 2020 Jun;22(6):852-859. doi: 10.1007/s12094-019-02195-8. Epub 2019 Aug 7. PubMed PMID: 31392644.
AÑO: 2020; IF: 3.405
|
|
Lorusso D, Hilpert F, Gonzalez Martin A, Rau J, Ottevanger P, Greimel E, Luck HJ, Selle F, Colombo N, Kroep JR, Mirza MR, Berger R, Pardo B, Grischke EM, Berton-Rigaud D, Martinez-Garcia J, Vergote I, Redondo A, Cardona A, Bastiere-Truchot L, du Bois A, Kurzeder C; PENELOPE trial investigators. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. Int J Gynecol Cancer. 2019 Sep;29(7):1141-1147. doi: 10.1136/ijgc-2019-000370. Epub 2019 Aug 15. PubMed PMID: 31420414.
AÑO: 2019; IF: 2.095
|
|
Gimeno L, Serrano-Lopez EM, Campillo JA, Canovas-Zapata MA, Acuna OS, Garcia-Cozar F, Martinez-Sanchez MV, Martinez-Hernandez MD, Soto-Ramirez MF, Lopez-Cubillana P, Martinez-Escribano J, Martinez-Garcia J, Corbalan-Garcia S, Alvarez-Lopez MR, Minguela A. KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. PubMed PMID: 33076479; PubMed Central PMCID: PMC7650600.
AÑO: 2020; IF: 6.639
|
|
Cascales-Campos PA, Gonzalez-Gil A, Fernandez-Luna E, Gil-Gomez E, Alconchel-Gago F, Romera-Garcia A, Martinez-Garcia J, Nieto-Diaz A, Barcelo-Valcarcel F, Gil-Martinez J. Urinary and fecal incontinence in patients with advanced ovarian cancer treated with CRS + HIPEC. Surg Oncol. 2021 Mar;36:115-119. doi: 10.1016/j.suronc.2020.12.001. Epub 2020 Dec 11. PubMed PMID: 33341606.
AÑO: 2021; IF: 2.388
|